Based on the reduced effector functions of CD8+ CTLs in COVID-19, studies have suggested that CD8+ T cells – unlike CD4+ Th cells – are immunoprotective in COVID-19 (204, 231). The gene discussed is CD8A; the disease is COVID-19.